Illumina, have today announced that they are part of a new collaboration with Adaptive Biotechnologies Corp., Microsoft, LabCorp and Providence Health & Services to decode the COVID-19 immune response and to provide open access to data from the virtual clinical trial starting in April 2020.

Read more about this project here